HPCL (886.35)
Support at 880 below 876. Resistance is at 894 above 899. (Buy for intraday with a stoploss below 876)
[MACD & STOCHASTICS BUY + VOLUME JUMP + ABV MOVING AVERAGES]
AUROBINDO PHARMA (814.75)
Support at 811 below 807. Resistance is at 825 above 832. (Buy for intraday with a stoploss below 807)
[STOCHASTCS BUY + VOLUME JUMP + ABV 100 & 200 DMA]
WOCKHARDT (1287)
Support at 1255 below 1232. Resistance is at 1295 above 1318. (Sell for intraday with a stoploss above 1318)
[MACD & STOCHASTICS SELL + BELOW PREVIOUS CLOSE + VOLUME JUMP + BELOW MOVING AVERAGES]
MINDTREE (1542.40)
Support at 1535 below 1520. Resistance is at 1568 above 1599 (Buy for intraday with a stoploss below 1520)
[MACD BUY + ABV PREVIOUS CLOSE + VOLUME JUMP + ABV MOVING AVERAGES]
HINDUSTAN UNILEVER (804.25)
Support at 796 below 792. Resistance is at 807 above 810 (Sell for intraday with a stoploss above 810)
[MACD SELL + BELOW MOVING AVERAGES + VOLUME JUMP]
Disclaimer: This report has been prepared by Geojit BNP Paribas Financial Services Limited (GBNPP), here in after referred to as GBNPP. GBNPP, a publicly listed company, is engaged in services of retail broking, credit, portfolio management and marketing investment products including mutual funds, life and general insurance and properties. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved). This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person. Persons into whose possession this document may come are required to observe these restrictions. Opinion expressed herein is our current opinion as of the date appearing on this report only. While we endeavor to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-looking statements are not predictions and may be subject to change without notice.
